| 196381 | 196381 | Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma | Active, not recruiting | No Results Available | Lymphoma | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003499 |
| 196382 | 196382 | Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma | Active, not recruiting | No Results Available | Lymphoma | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003498 |
| 196383 | 196383 | Antineoplaston Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | Active, not recruiting | No Results Available | Lung Cancer | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003497 |
| 196384 | 196384 | Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer | Active, not recruiting | No Results Available | Lung Cancer | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003496 |
| 196385 | 196385 | Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer | Active, not recruiting | No Results Available | Lung Cancer | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003495 |
| 196386 | 196386 | Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer | Active, not recruiting | No Results Available | Lung Cancer | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003494 |
| 196387 | 196387 | Combination Chemotherapy in Treating Patients With Multiple Myeloma | Completed | No Results Available | Multiple Myeloma and Plasma Cell Neoplasm | Drug: dexamethasone|Drug: pegylated liposomal doxorubicin hydrochloride|Drug: vincristine sulfate | https://ClinicalTrials.gov/show/NCT00003493 |
| 196388 | 196388 | Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer | Active, not recruiting | No Results Available | Lung Cancer | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003492 |
| 196389 | 196389 | Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer | Active, not recruiting | No Results Available | Lung Cancer | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003491 |
| 196390 | 196390 | Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma | Completed | No Results Available | Multiple Myeloma and Plasma Cell Neoplasm | Biological: sargramostim|Drug: cyclophosphamide|Drug: prednisone|Drug: vincristine sulfate | https://ClinicalTrials.gov/show/NCT00003490 |
| 196391 | 196391 | Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer | Active, not recruiting | No Results Available | Head and Neck Cancer | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003489 |
| 196392 | 196392 | Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus | Terminated | No Results Available | Esophageal Cancer | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003487 |
| 196393 | 196393 | Antineoplaston Therapy in Treating Patients With Colon Cancer | Withdrawn | No Results Available | Stage IV Colon Cancer|Recurrent Colon Cancer|Adenocarcinoma of the Colon | Drug: antineoplaston A10|Drug: antineoplaston AS2-1|Procedure: alternative product therapy|Procedure: biological therapy|Procedure: biologically based therapies|Procedure: cancer prevention intervention|Procedure: complementary and alternative therapy|Procedure: differentiation therapy | https://ClinicalTrials.gov/show/NCT00003486 |
| 196394 | 196394 | Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer | Active, not recruiting | No Results Available | Colorectal Cancer | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003485 |
| 196395 | 196395 | Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors | Completed | No Results Available | Brain and Central Nervous System Tumors|Neuroblastoma | Drug: carmustine|Drug: irinotecan hydrochloride|Procedure: surgical procedure|Radiation: iodine I 131 monoclonal antibody 81C6 | https://ClinicalTrials.gov/show/NCT00003484 |
| 196396 | 196396 | Antineoplaston Therapy in Treating Patients With Meningioma | Active, not recruiting | No Results Available | Brain and Central Nervous System Tumors | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003483 |
| 196397 | 196397 | Antineoplaston Therapy in Treating Patients With Ependymoma | Active, not recruiting | No Results Available | Brain and Central Nervous System Tumors | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003479 |
| 196398 | 196398 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors | Completed | No Results Available | Brain and Central Nervous System Tumors | Procedure: conventional surgery|Radiation: iodine I 131 monoclonal antibody 81C6|Radiation: radiation therapy | https://ClinicalTrials.gov/show/NCT00003478 |
| 196399 | 196399 | Antineoplaston Therapy in Treating Children With Visual Pathway Glioma | Recruiting | No Results Available | Brain and Central Nervous System Tumors | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003477 |
| 196400 | 196400 | Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors | Recruiting | No Results Available | Brain and Central Nervous System Tumors | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003476 |
| 196401 | 196401 | Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors | Recruiting | No Results Available | Brain and Central Nervous System Tumors | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003475 |
| 196402 | 196402 | Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme | Active, not recruiting | No Results Available | Brain and Central Nervous System Tumors | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003474 |
| 196403 | 196403 | Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas | Recruiting | No Results Available | Brain and Central Nervous System Tumors | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003473 |
| 196404 | 196404 | Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma | Active, not recruiting | No Results Available | Brain and Central Nervous System Tumors | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003472 |
| 196405 | 196405 | Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma | Active, not recruiting | No Results Available | Brain and Central Nervous System Tumors | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003471 |
| 196406 | 196406 | Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma | Recruiting | No Results Available | Brain and Central Nervous System Tumors | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003470 |
| 196407 | 196407 | Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System | Active, not recruiting | No Results Available | Brain and Central Nervous System Tumors | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003469 |
| 196408 | 196408 | Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma | Recruiting | No Results Available | Brain and Central Nervous System Tumors | Drug: antineoplaston A10|Drug: antineoplaston AS2-1 | https://ClinicalTrials.gov/show/NCT00003468 |
| 196409 | 196409 | Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma | Completed | No Results Available | Brain and Central Nervous System Tumors | Drug: carmustine|Drug: polifeprosan 20 with carmustine implant|Procedure: surgical procedure | https://ClinicalTrials.gov/show/NCT00003467 |
| 196410 | 196410 | Temozolomide in Treating Patients With Progressive Low-Grade Glioma | Completed | No Results Available | Brain and Central Nervous System Tumors | Drug: temozolomide | https://ClinicalTrials.gov/show/NCT00003466 |